HEC CJ PHARM: JOINT ANNOUNCEMENTMONTHLY UPDATEIN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATIONOF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.BY SUNSHINE LAKE PHARMA CO., LTD.BY WAY OF MERGER BY ABSORPTION OFYICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
HEC CJ PHARM: JOINT ANNOUNCEMENTMONTHLY UPDATEIN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATIONOF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.BY SUNSHINE LAKE PHARMA CO., LTD.BY WAY OF MERGER BY ABSORPTION OFYICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
HEC CJ PHARM: JOINT ANNOUNCEMENTMONTHLY UPDATEIN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATIONOF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.BY SUNSHINE LAKE PHARMA CO., LTD.BY WAY OF MERGER BY ABSORPTION OFYICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
HEC CJ PHARM: JOINT ANNOUNCEMENTEXTENSION OF TIME FOR DESPATCH OF THECOMPOSITE DOCUMENTANDMONTHLY UPDATEIN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OFYICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BYSUNSHINE LAKE PHARMA CO., LTD.BY WAY OF MERGER B
HEC CJ PHARM: EXCHANGE NOTICE - RESUMPTION OF TRADING
HEC CJ PHARM: TRADING HALT
HEC CJ PHARM: EXCHANGE NOTICE - TRADING HALT
HEC CJ PHARM: JOINT ANNOUNCEMENTMONTHLY UPDATEPURSUANT TO RULE 3.7 OF THE TAKEOVERS CODEIN RELATION TO THE POSSIBLE MERGER OFTHE COMPANY
HEC CJ PHARM: JOINT ANNOUNCEMENTMONTHLY UPDATEPURSUANT TO RULE 3.7 OF THE TAKEOVERS CODEIN RELATION TO THE POSSIBLE MERGER OFTHE COMPANY
HEC CJ PHARM: EXCHANGE NOTICE - RESUMPTION OF TRADING
HEC CJ PHARM: INSIDE INFORMATION IN RELATION TO A POSSIBLE TRANSFER OFSHARES IN THE COMPANYUNUSUAL PRICE MOVEMENTSANNOUNCEMENT PURSUANT TO RULE 3.7 OFTHE TAKEOVERS CODEAND INSIDE INFORMATIONIN RELATION TO A POSSIBLE MERGER OF THE COMPANYANDRESUMPTI
HEC CJ PHARM: TRADING HALT
HEC CJ PHARM: EXCHANGE NOTICE - TRADING HALT
HEC PHARM: CHANGE OF STOCK SHORT NAME
HEC PHARM: 2022 Report of the Board of Directors2022 Report of the Board of Supervisors2022 Consolidated Financial Statements2022 Annual ReportRe-appointment of the Auditor of the CompanyRenewal of the General Mandate to Issue Shares and Repurchase H
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATIONPLEDGE OF SHARES BY CONTROLLING SHAREHOLDER
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATIONUPDATE ON SHARE TRANSFER BY CONTROLLINGSHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION PLEDGE OF SHARES BY CONTROLLING SHAREHOLDER
YiChang HEC ChangJiang Pharmaceutical: 2021 Report of the Board of Directors 2021 Report of the Board of Supervisors 2021 Consolidated Financial Statements 2021 Annual Report Re-appointment of the Auditor of the Company Adjustment of the Remuneration of an
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
No Data
No Data